AJP - Lung Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Lung Cell Mol Physiol 291: L580-L587, 2006. First published May 12, 2006; doi:10.1152/ajplung.00270.2005
1040-0605/06 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/4/L580    most recent
00270.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, J. H.
Right arrow Articles by Kang, K. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, J. H.
Right arrow Articles by Kang, K. H.

Inhibition of matrix metalloproteinase-9 prevents neutrophilic inflammation in ventilator-induced lung injury

Je Hyeong Kim,1 Min Hyun Suk,2 Dae Wui Yoon,3 Seung Heon Lee,1 Gyu Young Hur,1 Ki Hwan Jung,1 Hae Cheol Jeong,1 Sung Yong Lee,1 Sang Yeub Lee,1 In Bum Suh,4 Chol Shin,1 Jae Jeong Shim,1 Kwang Ho In,1 Se Hwa Yoo,1 and Kyung Ho Kang1

1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, College of Medicine, Korea University, Seoul; 2Department of Nursing, College of Medicine, Pochon CHA University, Pochon; 3Institute of Human Genomic Study, Ansan Hospital, Korea University Medical Center, Ansan; and 4Department of Clinical Pathology, College of Medicine, Kangwon National University, Chuncheon, Korea

Submitted 23 June 2005 ; accepted in final form 27 April 2006


   ABSTRACT
TOP
 ABSTRACT
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Neutrophils are considered to play a central role in ventilator-induced lung injury (VILI). However, the pulmonary consequences of neutrophil accumulation have not been fully elucidated. Matrix metalloproteinase-9 (MMP-9) had been postulated to participate in neutrophil transmigration. The purpose of this study was to investigate the role of MMP-9 in the neutrophilic inflammation of VILI. Male Sprague-Dawley rats were divided into three groups: 1) low tidal volume (LVT), 7 ml/kg of tidal volume (VT); 2) high tidal volume (HVT), 30 ml/kg of VT; and 3) HVT with MMP inhibitor (HVT+MMPI). As a MMPI, CMT-3 was administered daily from 3 days before mechanical ventilation. Degree of VILI was assessed by wet-to-dry weight ratio and acute lung injury (ALI) scores. Neutrophilic inflammation was determined from the neutrophil count in the lung tissue and myeloperoxidase (MPO) activity in the bronchoalveolar lavage fluid (BALF). MMP-9 expression and activity were examined by immunohistochemical staining and gelatinase zymography, respectively. The wet-to-dry weight ratio, ALI score, neutrophil infiltration, and MPO activity were increased significantly in the HVT group. However, in the HVT+MMPI group, pretreatment with MMPI decreased significantly the degree of VILI, as well as neutrophil infiltration and MPO activity. These changes correlated significantly with MMP-9 immunoreactivity and MMP-9 activity. Most outcomes were significantly worse in the HVT+MMPI group compared with the LVT group. In conclusion, VILI mediated by neutrophilic inflammation is closely related to MMP-9 expression and activity. The inhibition of MMP-9 protects against the development of VILI through the downregulation of neutrophil-mediated inflammation.

metalloproteinase inhibitor; neutrophil; mechanical ventilators

THE PATHOGENESIS of acute respiratory distress syndrome (ARDS), which is the most severe form of acute lung injury (ALI), involves the disruption of the alveolar-capillary barrier, infiltration of inflammatory cells, and production of inflammatory mediators. Recently, matrix metalloproteinases (MMPs), which are implicated in the repair of the alveolar epithelium and clearance of foreign and noxious agents, have been reported to increase during the course of ARDS. In ALI, and mainly in ARDS, increased levels of MMP-2 and MMP-9 in the bronchoalveolar lavage (BAL) fluid (BALF) have been suggested to play a role in basement membrane disruption (9, 37, 47). Studies in various lung injury models show that MMPs are strongly related to the pathogenesis of lung injury and that MMP inhibitors (MMPI) decrease the extent of lung injury (2, 6, 8, 14, 53).

A histological hallmark of ARDS is the accumulation of neutrophils in the microvasculature of the lung, and neutrophils are considered to be central to the pathogenesis of ALI. After they are sequestered in the pulmonary vasculature, activated neutrophils adhere to the pulmonary endothelial cell layer and migrate through the interendothelial cell junctions down to the underlying basement membrane; the neutrophils that reach the basement membrane traverse this barrier via an undetermined mechanism (17, 52). MMPs have been postulated to participate in this process. It has been reported that MMP-9 is a major factor in neutrophil migration across basement membranes (10) and that MMP-9 inhibition by MMPI reduces neutrophil transmigration (21, 22). These findings suggest that MMP-9 plays an important role in neutrophil-mediated inflammation.

The majority of deaths of ALI and ARDS patients is attributable to multiple system organ failure (MSOF) rather than primary respiratory causes (3, 11, 31, 32, 42, 54). This phenomenon is due to the fact that ventilator-induced lung injury (VILI) plays a pivotal role in the initiation and/or propagation of a systemic inflammatory response that leads to MSOF in certain patients (43). Infiltration of neutrophils concomitant with the development of physiological signs of lung injury is a characteristic feature of VILI (4, 12, 19, 28, 33, 35, 38, 45, 49, 50). However, the pulmonary consequences of neutrophil accumulation within the alveoli during VILI have not been fully elucidated. In addition, MMPs may play an important role in the pathogenesis of VILI, although studies on the role of MMPs during VILI are very limited. To the best of our knowledge, there is only one report that shows VILI upregulation and gelatinase activation and that MMPI reduces the degree of VILI (13).

The aim of this study was to investigate the role of MMP-9 in the processes of neutrophil infiltration during VILI in an in vivo rat model through the observation of MMP-9 expression in lung tissues and of MMP-9 activity in the BALF with or without MMPI pretreatment.


   MATERIALS AND METHODS
TOP
 ABSTRACT
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 REFERENCES
 
Animals and mechanical ventilation. Specific pathogen-free, male, Sprague-Dawley rats, each weighing 280–320 g, were housed in pathogen-free rooms and maintained on laboratory chow with free access to food and water. This study was performed in accordance with the guidelines of the Animal Research Committee of Korea University and with the approval of the Ethics Committee of Korea University Medical Center.

The animals were randomly divided into the following experimental groups: 1) low tidal volume (VT) group (LVT group, n = 12) in which the rats were ventilated with LVT with positive end-expiratory pressure (PEEP); 2) high tidal volume group (HVT group, n = 12) in which the rats were ventilated with HVT without PEEP; and 3) HVT with MMPI pretreatment group (HVT+MMPI group, n = 12) in which the rats were pretreated with MMPI and ventilated with the same settings as for the HVT group. Each group subdivided into the histological set (n = 6) for wet-to-dry weight ratio measurements, histology, immunohistochemical staining, and the BAL set (n = 6) for myeloperoxidase (MPO) activity assays and gelatinase zymography.

Each rat was anesthetized with an intraperitoneal injection of 37 mg/kg thiopental, tracheostomized, and paralyzed with an intramuscular injection of 2 mg/kg vecuronium bromide. Mechanical ventilation was performed with a rodent volume ventilator (model 7025; Ugo Basile Biological Research Apparatus, Comerio-Varese, Italy). The rats in the LVT group were ventilated with the settings of 7 ml/kg VT, 3 cmH2O PEEP, and 40 breaths/min (36). Adequate modality for the formation of the VILI model was determined in preliminary studies using the following mechanical ventilator settings: 1) 20 ml/kg VT + 0 cmH2O PEEP + 25 breaths/min; 2) 30 ml/kg VT + 0 cmH2O PEEP + 40 breaths/min; and 3) 42 ml/kg VT + 0 cmH2O PEEP + 40 breaths/min. Examination of the lung tissues every 30 min allowed determination of the time and setting that gave pathological findings typical of VILI (12), i.e., severe diffuse alveolar damage, hyaline membranes, alveolar hemorrhage, and neutrophil infiltration. With the settings of 20 ml/kg VT + 0 cmH2O PEEP + 25 breaths/min, typical ALI was not apparent until after 4 h. With the settings of 42 ml/kg VT + 0 cmH2O PEEP + 40 breaths/min, severe pulmonary hemorrhage occurred 30 min after mechanical ventilation, and most of the rats expired after 30–60 min. Histological examination showed severe intra-alveolar hemorrhage with minimal evidence of other ALI indicators. With the settings of 30 ml/kg VT + 0 cmH2O PEEP + 40 breaths/min, typical ALI findings developed within the period of the experiment. These changes were most prominent at about 2 h after mechanical ventilation. Therefore, the optimal mechanical ventilator modality for the HVT and HVT+MMPI groups was the setting of 30 ml/kg VT + 0 cmH2O PEEP + 40 breaths/min for 2 h, and the rats in the LVT group were also ventilated for 2 h.

MMPI. The rats in the HVT+MMPI group were administered 6-demethyl-6-deoxy-4-dedimethylamino-tetracycline (CMT-3; donated by Collagenex Pharmaceuticals, Newtown, PA). This chemically modified, non-antibiotic tetracycline was administered by gavage daily from 3 days before mechanical ventilation at 20 mg/kg in 1 ml of vehicle, which consisted of N-methyl pyrrolidone, propylparaben, methylparaben, ethanol, and 2% carboxymethyl cellulose. The rats in the LVT and HVT groups were gavaged with 1 ml of vehicle during the same period.

Tissue preparation, wet-to-dry weight ratios, and BALF assays. After mechanical ventilation, the rats' chests were opened by midsternal incision, and the rats were exsanguinated. The heart and lungs were removed en bloc. After ligation of the left main bronchus, the left lung was excised and weighed in a tared container. The lung was then dried in a drying oven until a constant weight was obtained, and the wet-to-dry weight ratio was calculated. After excision of the left lung, the lung tissues were prepared as follows for the histological and immunohistochemical examinations. The right main bronchus was instilled and fixed immediately with 4% paraformaldehyde at a hydrostatic pressure of 20 cmH2O, and the specimen was floated in fixative for 48 h. After excision of the lower lobe, paraffin blocks were prepared by dehydration of the lung tissues with ethanol and embedding in paraffin.

For the BAL group rats, after euthanasia by exsanguination, the thorax was opened, and three BAL procedures were performed, each with 2 ml of PBS. The retrieval fluid was centrifuged (2,000 g at 4°C) for 10 min, and the supernatants were divided into aliquots and stored at –70°C until analysis for MPO activity and gelatinase zymography.

Evaluation of degree of VILI and neutrophil infiltration. The posterior portions of the right lower lobe were sectioned at 4-µm thickness, placed on glass slides, and stained with hematoxylin-eosin. A pathologist, who was blinded to the protocol and experimental groups, examined the degree of lung injury and graded the specimens by ALI score. ALI was scored based on: 1) alveolar capillary congestion; 2) hemorrhage; 3) infiltration or aggregation of neutrophils in the air space or the vessel wall; and 4) thickness of the alveolar wall/hyaline membrane formation (19). Each item was graded according to the following five-point scale: 0 = minimal (little) damage; 1 = mild damage; 2 = moderate damage; 3 = severe damage; and 4 = maximal damage (19). The degree of VILI was assessed by sum of scores of items from 0 to 16 in five high-power fields (HPF, magnification x400) randomly. The average sum of each field score was compared among groups.

To evaluate more accurately the recruitment of polymorphonuclear (PMN) leukocytes, we stained sections with 3,3'-diaminobenzidine and counterstained with toluidine blue. The PMN cells, which were observed as peroxidase-positive blue cytoplasmic cells, were counted in 10 consecutive HPFs (magnification x400) (41).

Immunohistochemical staining for MMP-9. Immunohistochemical staining for MMP-9 was performed as follows. PBS that contained 0.05% Tween 20 and 2% normal goat serum was used as the antibody diluent after blocking endogenous peroxidase with 0.3% H2O2 in methanol. The sections were incubated overnight at 4°C with mouse monoclonal antibodies against MMP-9 (diluted 1:500; Oncogene Science, Cambridge, MA) and then washed with PBS to remove excess primary antibody. The sections were then incubated with biotinylated horse anti-mouse IgG (Vector Laboratories, Burlingame, CA) at a dilution of 1:200 for 1 h at room temperature. Bound antibody was visualized according to the standard avidin-biotin-peroxidase complex protocol. The immunoreactivities of the lung tissue specimens were scored independently by two people using the following scheme: 0 = none; 1 = mild; 2 = moderate; 3 = strongly abundant immunoreactivity. MMP-9 expression was examined randomly in five HPFs (magnification x400), and the sums of the scores for each field score were compared.

Determination of MPO activity. Pulmonary hemorrhage is one of the characteristic findings in the VILI model. Because neutrophil-mediated inflammation may be overestimated in examinations of lung tissues and BALF cell counts, MPO activity was determined in cell-free BALF according to a previously described method (16), with minor modifications. Aliquots of 50 µl of cell-free BALF were mixed in microtiter plates with 200 µl of O-dianisidine dihydrochloride (1.25 mg/ml in PBS) plus BSA (0.1% wt/vol) containing H2O2 (0.05% = 0.4 mM). The MPO activities are expressed as changes in absorbance at 450 nm.

Gelatinase zymography. Gelatinase zymography was performed with modifications to a previously published protocol (15, 23). The protein concentration of each sample was measured with the Bio-Rad Protein Assay Kit (Bio-Rad Laboratories, Hercules, CA). The volume of BALF that contained 100 µg of protein was mixed with an equal volume of sample buffer [80 mmol/l Tris·HCl (pH 6.8), 4% SDS, 10% glycerol, 0.01% bromphenol blue]. Recombinant human MMP-9 (Sigma Chemical, St. Louis, MO) was diluted in collagenase buffer, mixed with an equal volume of sample buffer, and loaded onto the gel as a standard. As a negative control, sample buffer was loaded onto each gel. For electrophoresis, 8% SDS-polyacrylamide resolving gels that contained 1 mg/ml gelatin were overlaid with 5% stacking gels, and the samples were loaded and run at 4°C (25 mA/gel). After electrophoresis, the gels were rinsed briefly with distilled water and washed three times (15 min each) with 150 ml of 2.5% Triton X-100 solution on a rotary shaker. The gels were then incubated at 37°C for 66 h in 250 ml of 50 mmol/l Tris·HCl (pH 7.5) that contained 10 mmol/l CaCl2 and 0.02% NaN3. After incubation, the gels were stained with 50% methanol, 10% acetic acid, and 0.1% Coomassie blue R-250 and then destained with 10% methanol and 10% acetic acid. After being destained, the gels were immersed in distilled water for 20 min and scanned immediately. MMP activity was determined by densitometry and Quantity One 1-D Analysis Software (Bio-Rad Laboratories). Normalization of integrated densities was performed by dividing values obtained from each sample by the fraction of recombinant human MMP-9 standards run in parallel in the same gel.

Statistical analysis. All the data are expressed as means ± SD. Statistical analysis was performed using the nonparametric Mann-Whitney's U-test and Kruskal-Wallis methods to determine intergroup differences. A P value of <0.05 was taken to be statistically significant. Spearman's rank correlation coefficient was used to correlate the MMP-9 activity in BALF and immunoreactivity in tissue with neutrophil infiltration and degree of VILI.


   RESULTS
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 REFERENCES
 
Wet-to-dry weight ratios. The wet-to-dry weight ratios of the LVT, HVT, and HVT+MMPI groups were 4.70 ± 0.14, 6.82 ± 1.28, and 4.92 ± 0.28, respectively, with significant differences between the groups (P = 0.001 by the Kruskal-Wallis test). The HVT group had a significantly higher wet-to-dry weight ratio than either the LVT or HVT+MMPI group (P = 0.002). In addition, the HVT+MMPI group showed a higher wet-to-dry weight ratio than the LVT group (P = 0.041; Fig. 1A).


Figure 1
View larger version (9K):
[in this window]
[in a new window]
  		Fig. 1. The wet-to-dry weight ratios (A) and acute lung injury scores (B) are significantly different between the groups (P = 0.001 by the Kruskal-Wallis test). The high tidal volume (HVT) group shows significantly higher values than the low tidal volume (LVT) and HVT+matrix metalloproteinase inhibitor (HVT+MMPI) groups, and the HVT+MMPI group shows a higher wet-to-dry weight ratio than the LVT group (*P < 0.05).

 
ALI scores. After mechanical ventilation, the HVT group showed high levels of intra-alveolar exudates, hyaline membrane formation, inflammatory cell infiltration, intra-alveolar hemorrhage, and interstitial edema (Fig. 2B). However, significant ALI findings were absent and only mild inflammatory cellular infiltration was present in the LVT group (Fig. 2A). The HVT+MMPI group displayed moderately increased inflammatory cellular infiltration and intra-alveolar hemorrhage, compared with the LVT group, but the overall degree of lung injury in the HVT+MMPI group was significantly lower than in the HVT group (Fig. 2C).


Figure 2
View larger version (81K):
[in this window]
[in a new window]
  		Fig. 2. B: histological examination shows high levels of intra-alveolar exudates, hyaline membrane formation, inflammatory cell infiltration, intra-alveolar hemorrhage, and interstitial edema in the HVT group. A: in the LVT group, significant acute lung injury findings are absent and only mild inflammatory cellular infiltration is present. C: the HVT+MMPI group shows a moderately higher level of inflammatory cellular infiltration and intra-alveolar hemorrhage than the LVT group, whereas the overall degree of lung injury in the HVT+MMPI group is significantly lower than in the HVT group.

 
The degrees of VILI, as expressed by ALI scores, in the LVT, HVT, and HVT+MMPI groups were 3.25 ± 1.17, 12.83 ± 1.17, and 4.67 ± 0.52, respectively, with significant differences between the three groups (P = 0.001 by the Kruskal-Wallis test). The HVT group showed a significantly higher ALI score than the LVT and HVT+MMPI groups (P = 0.001 compared with the LVT group and P = 0.002 compared with the HVT+MMPI group). In comparisons of the LVT and HVT+MMPI groups, the HVT+MMPI group showed the higher ALI score (P = 0.029; Fig. 1B).

Neutrophil infiltration and BALF MPO activity. The levels of neutrophil infiltration in 10 HPFs of the LVT, HVT, and HVT+MMPI groups were 24.33 ± 3.33, 202.17 ± 17.61, and 86.50 ± 13.55, respectively, with significant differences between the groups (P = 0.001 by the Kruskal-Wallis test). The HVT group showed significantly higher neutrophil infiltration than the LVT and HVT+MMPI groups (P = 0.002 compared with LVT and HVT+MMPI groups). In comparisons of the LVT and HVT+MMPI groups, the HVT+MMPI group showed the higher level of neutrophil infiltration (P = 0.002; Fig. 3A).


Figure 3
View larger version (9K):
[in this window]
[in a new window]
  		Fig. 3. The levels of neutrophil infiltration (A) and myeloperoxidase (MPO) activity (B) are significantly different among the groups (P = 0.001 by the Kruskal-Wallis test). The HVT group shows significantly higher levels than the LVT and HVT+MMPI groups, and the HVT+MMPI group shows a higher wet-to-dry weight ratio than the LVT group (*P < 0.05). HPFs, high-power fields.

 
The optical densities of the MPO activities in the BALFs of the LVT, HVT, and HVT+MMPI groups were 0.0296 ± 0.0046, 0.1193 ± 0.0525, and 0.0488 ± 0.0138, respectively, with significant differences between the groups (P = 0.001 by the Kruskal-Wallis test). The HVT group showed significantly higher MPO activity than the LVT and HVT+MMPI groups (P = 0.002 compared with the LVT group and P = 0.004 compared with the HVT+MMPI group). In comparisons of the LVT and HVT+MMPI groups, the HVT+MMPI group showed the higher level of MPO activity (P = 0.015; Fig. 3B).

Immunohistochemical staining for MMP-9. The expression of MMP-9 was examined by immunohistochemical staining. In the LVT group, the immunoreactivity of MMP-9 was minimal in the low (x100) and high (x400) power fields (Fig. 4A). However, the HVT group showed strong heterogeneous expression in low power fields, and immunoreactivity was observed at or around the inflammatory cells in HPF (Fig. 4B). The HVT+MMPI group expressed significantly less MMP-9 than the HVT group (Fig. 4C).


Figure 4
View larger version (83K):
[in this window]
[in a new window]
  		Fig. 4. A: in the LVT group, MMP-9 immunoreactivity is minimal in the low- (x100) and high- (x400) power fields. B: the HVT group shows strong heterogeneous expression in the low-power fields, and immunoreactivity is observed at or around the inflammatory cells in the HPFs. C: the HVT+MMPI group expresses significantly less MMP-9 than the HVT group.

 
According to the semiquantification system using the four-point scale, the levels of MMP-9 expression in the LVT, HVT, and HVT+MMPI groups were 3.33 ± 2.07, 12.17 ± 2.79, and 3.60 ± 1.95, respectively, with significant differences between the three groups (P = 0.004 by the Kruskal-Wallis test). The HVT group showed significantly higher immunoreactivity than the LVT and HVT+MMPI groups (P = 0.004 compared with the HVT+MMPI group and P = 0.002 compared with the LVT group). In comparisons of the LVT and the HVT+MMPI groups, the HVT+MMPI group showed the higher level of MMP-9 expression, although this difference was not statistically significant (P = 0.931; Fig. 5A).


Figure 5
View larger version (20K):
[in this window]
[in a new window]
  		Fig. 5. A: semiquantification of MMP-9 immunoreactivity. The levels of MMP-9 immunoreactivity are significantly different among the 3 groups (P = 0.004 by the Kruskal-Wallis test). The HVT group shows significantly higher immunoreactivity than the LVT and HVT+MMPI groups. Comparisons of the LVT and HVT+MMPI groups show that the HVT+MMPI group shows higher expression of MMP-9, although this difference is not statistically significant. Gelatinase zymography (B) and the relative densitometry units (C) of MMP-9 activity show significant differences among the groups (P = 0.001 by the Kruskal-Wallis test). The HVT group shows significantly higher MMP-9 activity than the LVT and HVT+MMPI groups. Comparing the LVT and HVT+MMPI groups, the HVT+MMPI group shows the higher MMP-9 activity (*P < 0.05).

 
Using Spearman's correlation, MMP-9 immunoreactivity in tissues was found to have a significant correlation with neutrophil infiltration (r = 0.713, P = 0.001), MPO activity (r = 0.674, P = 0.002), wet-to-dry weight ratio (r = 0.750, P = 0.000), and ALI score (r = 0.704, P = 0.001).

Gelatinase zymography. Gelatinase activity was examined in the BALFs using the zymography techniques described previously. We found bands of degradation around 92 kDa that were consistent with MMP-9 (Fig. 5B). In addition, incubation with EDTA completely eliminated this band of gelatinase activity, which is consistent with the known properties of MMP-9. The relative densitometry units of MMP-9 activity for the LVT, HVT, and HVT+MMPI groups were 84.12 ± 4.37, 158.44 ± 23.45, and 95.77 ± 5.95, respectively, which were significantly different between the groups (P = 0.001 by the Kruskal-Wallis test). The HVT group showed significantly higher MMP-9 activity than the LVT and HVT+MMPI groups (P = 0.002 compared with the LVT and HVT+MMPI groups). In comparisons of the LVT and HVT+MMPI groups, the HVT+MMPI group showed the higher level of MMP-9 activity (P = 0.002; Fig. 5C).

In Spearman's correlation analysis, MMP-9 activity in BALF correlated significantly with neutrophil infiltration (r = 0.909, P = 0.000), MPO activity (r = 0.785, P = 0.000), wet-to-dry weight ratio (r = 0.775, P = 0.000), and ALI score (r = 0.846, P = 0.000).


   DISCUSSION
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
REFERENCES
 
In the present study, injurious mechanical ventilation strategy with HVT without PEEP increased the degree of VILI and neutrophil infiltration, which were significantly correlated with the level of MMP-9 expression in lung tissue and MMP-9 activity in the BALF. In the case of MMP-9 inhibition by CMT-3 pretreatment, VILI was significantly prevented, and this was associated with decreases in neutrophil infiltration and MMP-9 expression and activity. These results indicate that MMP-9 plays an important role in promoting neutrophil transmigration and in the development of VILI in rats.

MMPs are zinc- and calcium-dependent endopeptidases that have the ability to cleave one or several extracellular matrix constituents. MMPs can be classified into four groups on the basis of sequence homology and substrate specificity: interstitial collagenase, neutrophil collagenase, collagenase-3, and membrane-type metalloproteinases. We investigated the unusual activity of neutrophil collagenase in the pathogenesis of VILI, which is associated with neutrophil-mediated inflammation. Neutrophil collagenase consists of the 72- and 92-kDa gelatinases, MMP-2 and MMP-9, respectively. MMP-2 is synthesized by a wide variety of cells, including fibroblasts, endothelial cells, and alveolar epithelial cells. MMP-9 is produced mainly by inflammatory cells, such as polymorphonuclear neutrophils, monocytes, macrophages, eosinophils, and lymphocytes. In particular, activated neutrophils secrete significant amounts of MMP-9, which is a major elastolytic MMP (40) but not of MMP-2 (34).

The exuberant or aberrant expression of MMPs can cause tissue damage and has been associated with a variety of lung diseases. The higher concentration of MMP-9 may be induced by the increased number of neutrophils in the BALF of ARDS patients, as MMP-9 is the type IV collagenase that is found in neutrophils (27). Thus the MMPs have the ability to degrade the type IV collagen-rich basement membrane (29, 30). Although macrophages are known to produce MMP-2 and MMP-9, increases in the numbers of macrophages are not correlated with increases in MMP-9 levels (7). Because MMP-9 is expressed by inflammatory cells, the role of MMP-9 in neutrophil migration has been studied.

Physical stretching and shearing forces caused by mechanical ventilation induce the recruitment of inflammatory cells and the production of inflammatory mediators (18, 20, 46, 48, 50). Of these factors, neutrophils and their mediators have been implicated in the development of both VILI and ALI (4, 12, 19, 20, 28, 33, 35, 38, 45, 49, 50). However, VILI can be caused by mechanisms independent of neutrophils such as alveolar instability (44) or decreased lung edema clearance (24). Neutrophil involvement in lung injury can be conceptualized in terms of sequential stages, beginning with sequestration in the pulmonary microvasculature, followed by adhesion and activation, and culminating in the production of an "effector" response, i.e., the generation of reactive oxygen species or the release of proteolytic enzymes (25). Sequestered neutrophils adhere to the pulmonary endothelial cell layer and migrate through the interendothelial cell junctions to the underlying basement membrane. These processes involve several cellular adhesion molecules. Physiological studies have shown that the neutrophil that reaches the basement membrane pauses before traversing the basement membrane, using an undetermined mechanism to penetrate this barrier (17, 52). Although MMPs have been postulated to be active in this process, studies clarifying their role have been controversial. According to some studies, MMP-9 is a major factor in neutrophil migration across the basement membrane in vitro (10) and promotes neutrophil migration in both pancreatitis-associated lung injury (21) and lipopolysaccharide-induced goblet cell metaplasia (22) in the rat. However, MMPI is ineffective at stopping neutrophil migration through intact endothelial cell monolayers and basement membrane matrixes in vitro (26), and neutrophils from MMP-9-deficient mice showed no defect in transendothelial migration in vitro (1). Furthermore, MMP-9-deficient mice have normal neutrophil emigration into the lungs, peritoneum, and skin (5). Thus the role of MMP-9 release and digestion of extravascular matrix components during migration remains uncertain (51). Therefore, we investigated the role of MMP-9 and MMPI in the pathogenesis of VILI.

In the present study, the degree of MMP-9 expression observed by immunohistochemical staining and the levels of MMP-9 activity in the BALF detected by gelatinase zymography showed significant correlations with the levels of neutrophil infiltration, MPO activity in BALF, and the degree of VILI observed by ALI score and wet-to-dry weight ratio in rat model. This suggests that the migration of activated neutrophils through the extravascular milieu is aided by digestion with MMP-9. MMP-9 expression, MMP-9 activity, and neutrophil infiltration were decreased significantly by CMT-3 treatment, which suggests that MMPI prevents neutrophil migration. The attenuation of neutrophil infiltration by MMPI was related to a decrease in the degree of VILI. CMT-3, which was used as the MMPI in the present study, is a nonantimicrobial tetracycline, chemically modified to enhance its collagenase-inhibitory property. CMT-3 is the most potent inhibitor of both MMP-2 and MMP-9 (39), but since MMP-2 is not produced by activated neutrophils (34), we believe that CMT-3 treatment primarily blocked MMP-9 in the present study. However, in the results, all outcomes with an exception of MMP-9 immunoreactivity were significantly worse in the HVT+MMPI group compared with the LVT group. Although the exact mechanisms are unclear, the plausible explanation is that VILI is caused by complex of multiple pathogenesis other than neutrophils and MMP-9.

In conclusion, inhibition of MMP-9 significantly, but not completely, reduces the degree of lung injury induced by injurious mechanical ventilation by downregulating neutrophil-mediated inflammation as well as MMP-9 expression and activity. These findings suggest that MMP-9 plays a pivotal role in the pathogenesis of VILI and provide further evidence that MMPI has the potential to prevent to a substantial degree VILI that cannot be completely protected against by lung-protective ventilation strategies.


   FOOTNOTES
 

Address for reprint requests and other correspondence: K. H. Kang, Division of Pulmonology and Critical Care Medicine, Dept. of Internal Medicine, Korea Univ. Guro Hospital #97, Gurodong-Gil, Guro-Gu, Seoul, 152-703 Korea (e-mail: kkhchest{at}korea.ac.kr)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


   REFERENCES
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Allport JR, Lim YC, Shipley JM, Senior RM, Shapiro SD, Matsuyoshi N, Vestweber D, and Luscinskas FW. Neutrophils from MMP-9- or neutrophil elastase-deficient mice show no defect in transendothelial migration under flow in vitro. J Leukoc Biol 71: 821–828, 2002.[Abstract/Free Full Text]
  2. Araya J, Maruyama M, Sassa K, Fujita T, Hayashi R, Matsui S, Kashii T, Yamashita N, Sugiyama E, and Kobayashi M. Ionizing radiation enhances matrix metalloproteinase-2 production in human lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 280: L30–L38, 2001.[Abstract/Free Full Text]
  3. Bartlett RH, Morris AH, Fairley HB, Hirsch R, O'Connor N, and Pontoppidan H. A prospective study of acute hypoxic respiratory failure. Chest 89: 684–689, 1986.[Abstract/Free Full Text]
  4. Belperio JA, Keane MP, Burdick MD, Londhe V, Xue YY, Li K, Phillips RJ, and Strieter RM. Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury. J Clin Invest 110: 1703–1716, 2002.[CrossRef][ISI][Medline]
  5. Betsuyaku T, Shipley JM, Liu Z, and Senior RM. Neutrophil emigration in the lungs, peritoneum, and skin does not require gelatinase B. Am J Respir Cell Mol Biol 20: 1303–1309, 1999.[Abstract/Free Full Text]
  6. Carney DE, Lutz CJ, Picone AL, Gatto LA, Ramamurthy NS, Golub LM, Simon SR, Searles B, Paskanik A, Snyder K, Finck C, Schiller HJ, and Nieman GF. Matrix metalloproteinase inhibitor prevents acute lung injury after cardiopulmonary bypass. Circulation 100: 400–406, 1999.[Abstract/Free Full Text]
  7. Corbel M, Boichot E, and Lagente V. Role of gelatinases MMP-2 and MMP-9 in tissue remodeling following acute lung injury. Braz J Med Biol Res 33: 749–754, 2000.[ISI][Medline]
  8. D'Ortho MP, Jarreau PH, Delacourt C, Macquin-Mavier I, Levame M, Pezet S, Harf A, and Lafuma C. Matrix metalloproteinase and elastase activities in LPS-induced acute lung injury in guinea pigs. Am J Physiol Lung Cell Mol Physiol 266: L209–L216, 1994.[Abstract/Free Full Text]
  9. Delclaux C, d'Ortho MP, Delacourt C, Lebargy F, Brun-Buisson C, Brochard L, Lemaire F, Lafuma C, and Harf A. Gelatinases in epithelial lining fluid of patients with adult respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 272: L442–L451, 1997.[Abstract/Free Full Text]
  10. Delclaux C, Delacourt C, D'Ortho MP, Boyer V, Lafuma C, and Harf A. Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. Am J Respir Cell Mol Biol 14: 288–295, 1996.[Abstract]
  11. Doyle RL, Szaflarski N, Modin GW, Wiener-Kronish JP, and Matthay MA. Identification of patients with acute lung injury. Predictors of mortality. Am J Respir Crit Care Med 152: 1818–1824, 1995.[Abstract]
  12. Dreyfuss D and Saumon G. Ventilator-induced lung injury: lessons from experimental studies. Am J Respir Crit Care Med 157: 294–323, 1998.
  13. Foda HD, Rollo EE, Drews M, Conner C, Appelt K, Shalinsky DR, and Zucker S. Ventilator-induced lung injury upregulates and activates gelatinases and EMMPRIN: attenuation by the synthetic matrix metalloproteinase inhibitor, Prinomastat (AG3340). Am J Respir Cell Mol Biol 25: 717–724, 2001.[Abstract/Free Full Text]
  14. Gibbs DF, Shanley TP, Warner RL, Murphy HS, Varani J, and Johnson KJ. Role of matrix metalloproteinases in models of macrophage-dependent acute lung injury. Evidence for alveolar macrophage as source of proteinases. Am J Respir Cell Mol Biol 20: 1145–1154, 1999.[Abstract/Free Full Text]
  15. Hibbs MS, Hasty KA, Seyer JM, Kang AH, and Mainardi CL. Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. J Biol Chem 260: 2493–2500, 1985.[Abstract/Free Full Text]
  16. Hirano S. Migratory responses of PMN after intraperitoneal and intratracheal administration of lipopolysaccharide. Am J Physiol Lung Cell Mol Physiol 270: L836–L845, 1996.[Abstract/Free Full Text]
  17. Hurley JV. An electron microscopic study on leukocytic emigration and vascular permeability in rat skin. Aust J Exp Biol Med Sci 41: 171–186, 1963.[ISI][Medline]
  18. Imai Y, Kawano T, Miyasaka K, Takata M, Imai T, and Okuyama K. Inflammatory chemical mediators during conventional ventilation and during high frequency oscillatory ventilation. Am J Respir Crit Care Med 150: 1550–1554, 1994.[Abstract]
  19. Imanaka H, Shimaoka M, Matsuura N, Nishimura M, Ohta N, and Kiyono H. Ventilator-induced lung injury is associated with neutrophil infiltration, macrophage activation, and TGF-beta 1 mRNA upregulation in rat lungs. Anesth Analg 92: 428–436, 2001.[Abstract/Free Full Text]
  20. Kawano T, Mori S, Cybulsky M, Burger R, Ballin A, Cutz E, and Bryan AC. Effect of granulocyte depletion in a ventilated surfactant-depleted lung. J Appl Physiol 62: 27–33, 1987.[Abstract/Free Full Text]
  21. Keck T, Balcom JH IV, Fernandez-del Castillo C, Antoniu BA, and Warshaw AL. Matrix metalloproteinase-9 promotes neutrophil migration and alveolar capillary leakage in pancreatitis-associated lung injury in the rat. Gastroenterology 122: 188–201, 2002.[CrossRef][ISI][Medline]
  22. Kim JH, Lee SY, Bak SM, Suh IB, Lee SY, Shin C, Shim JJ, In KH, Kang KH, and Yoo SH. Effects of matrix metalloproteinase inhibitor on LPS-induced goblet cell metaplasia. Am J Physiol Lung Cell Mol Physiol 287: L127–L133, 2004.[Abstract/Free Full Text]
  23. Kleiner DE and Stetler-Stevenson WG. Quantitative zymography: detection of picogram quantities of gelatinases. Anal Biochem 218: 325–329, 1994.[CrossRef][ISI][Medline]
  24. Lecuona E, Saldias F, Comellas A, Ridge K, Guerrero C, and Sznajder JI. Ventilator-associated lung injury decreases lung ability to clear edema in rats. Am J Respir Crit Care Med 159: 603–609, 1999.[Abstract/Free Full Text]
  25. Lee WL and Downey GP. Neutrophil activation and acute lung injury. Curr Opin Crit Care 7: 1–7, 2001.[CrossRef][Medline]
  26. Mackarel AJ, Cottell DC, Russell KJ, FitzGerald MX, and O'Connor CM. Migration of neutrophils across human pulmonary endothelial cells is not blocked by matrix metalloproteinase or serine protease inhibitors. Am J Respir Cell Mol Biol 20: 1209–1219, 1999.[Abstract/Free Full Text]
  27. Masure S, Proost P, Van Damme J, and Opdenakker G. Purification and identification of 91-kDa neutrophil gelatinase. Release by the activating peptide interleukin-8. Eur J Biochem 198: 391–398, 1991.[ISI][Medline]
  28. Matsuoka T, Kawano T, and Miyasaka K. Role of high-frequency ventilation in surfactant-depleted lung injury as measured by granulocytes. J Appl Physiol 76: 539–544, 1994.[Abstract/Free Full Text]
  29. Mignatti P and Rifkin DB. Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 73: 161–195, 1993.[Free Full Text]
  30. Mignatti P and Rifkin DB. Plasminogen activators and matrix metalloproteinases in angiogenesis. Enzyme Protein 49: 117–137, 1996.[ISI][Medline]
  31. Monchi M, Bellenfant F, Cariou A, Joly LM, Thebert D, Laurent I, Dhainaut JF, and Brunet F. Early predictive factors of survival in the acute respiratory distress syndrome. A multivariate analysis. Am J Respir Crit Care Med 158: 1076–1081, 1998.[Abstract/Free Full Text]
  32. Montgomery AB, Stager MA, Carrico CJ, and Hudson LD. Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 132: 485–489, 1985.[ISI][Medline]
  33. Ohta N, Shimaoka M, Imanaka H, Nishimura M, Taenaka N, Kiyono H, and Yoshiya I. Glucocorticoid suppresses neutrophil activation in ventilator-induced lung injury. Crit Care Med 29: 1012–1016, 2001.[CrossRef][ISI][Medline]
  34. Opdenakker G, Van den Steen PE, Dubois B, Nelissen I, Van Coillie E, Masure S, Proost P, and Van Damme J. Gelatinase B functions as regulator and effector in leukocyte biology. J Leukoc Biol 69: 851–859, 2001.[Abstract/Free Full Text]
  35. Quinn DA, Moufarrej RK, Volokhov A, and Hales CA. Interactions of lung stretch, hyperoxia, and MIP-2 production in ventilator-induced lung injury. J Appl Physiol 93: 517–525, 2002.[Abstract/Free Full Text]
  36. Ricard JD, Dreyfuss D, and Saumon G. Production of inflammatory cytokines in ventilator-induced lung injury: a reappraisal. Am J Respir Crit Care Med 163: 1176–1180, 2001.[Abstract/Free Full Text]
  37. Ricou B, Nicod L, Lacraz S, Welgus HG, Suter PM, and Dayer JM. Matrix metalloproteinases and TIMP in acute respiratory distress syndrome. Am J Respir Crit Care Med 154: 346–352, 1996.[Abstract]
  38. Rimensberger PC, Fedorko L, Cutz E, and Bohn DJ. Attenuation of ventilator-induced acute lung injury in an animal model by inhibition of neutrophil adhesion by leumedins (NPC 15669). Crit Care Med 26: 548–555, 1998.[CrossRef][ISI][Medline]
  39. Seftor RE, Seftor EA, De Larco JE, Kleiner DE, Leferson J, Stetler-Stevenson WG, McNamara TF, Golub LM, and Hendrix MJ. Chemically modified tetracyclines inhibit human melanoma cell invasion and metastasis. Clin Exp Metastasis 16: 217–225, 1998.[CrossRef][ISI][Medline]
  40. Senior RM, Griffin GL, Fliszar CJ, Shapiro SD, Goldberg GI, and Welgus HG. Human 92- and 72-kilodalton type IV collagenases are elastases. J Biol Chem 266: 7870–7875, 1991.[Abstract/Free Full Text]
  41. Shim JJ, Dabbagh K, Ueki IF, Dao-Pick T, Burgel PR, Takeyama K, Tam DC, and Nadel JA. IL-13 induces mucin production by stimulating epidermal growth factor receptors and by activating neutrophils. Am J Physiol Lung Cell Mol Physiol 280: L134–L140, 2001.[Abstract/Free Full Text]
  42. Sloane PJ, Gee MH, Gottlieb JE, Albertine KH, Peters SP, Burns JR, Machiedo G, and Fish JE. A multicenter registry of patients with acute respiratory distress syndrome. Physiology and outcome. Am Rev Respir Dis 146: 419–426, 1992.[ISI][Medline]
  43. Slutsky AS and Tremblay LN. Multiple system organ failure. Is mechanical ventilation a contributing factor? Am J Respir Crit Care Med 157: 1721–1725, 1998.
  44. Steinberg JM, Schiller HJ, Halter JM, Gatto LA, Lee HM, Pavone LA, and Nieman GF. Alveolar instability causes early ventilator-induced lung injury independent of neutrophils. Am J Respir Crit Care Med 169: 57–63, 2004.[Abstract/Free Full Text]
  45. Sugiura M, McCulloch PR, Wren S, Dawson RH, and Froese AB. Ventilator pattern influences neutrophil influx and activation in atelectasis-prone rabbit lung. J Appl Physiol 77: 1355–1365, 1994.[Abstract/Free Full Text]
  46. Takata M, Abe J, Tanaka H, Kitano Y, Doi S, Kohsaka T, and Miyasaka K. Intraalveolar expression of tumor necrosis factor-alpha gene during conventional and high-frequency ventilation. Am J Respir Crit Care Med 156: 272–279, 1997.[Abstract/Free Full Text]
  47. Torii K, Iida K, Miyazaki Y, Saga S, Kondoh Y, Taniguchi H, Taki F, Takagi K, Matsuyama M, and Suzuki R. Higher concentrations of matrix metalloproteinases in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. Am J Respir Crit Care Med 155: 43–46, 1997.[Abstract]
  48. Tremblay L, Valenza F, Ribeiro SP, Li J, and Slutsky AS. Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model. J Clin Invest 99: 944–952, 1997.[ISI][Medline]
  49. Tremblay LN and Slutsky AS. Ventilator-induced injury: from barotrauma to biotrauma. Proc Assoc Am Physicians 110: 482–488, 1998.[ISI][Medline]
  50. Tsuno K, Miura K, Takeya M, Kolobow T, and Morioka T. Histopathologic pulmonary changes from mechanical ventilation at high peak airway pressures. Am Rev Respir Dis 143: 1115–1120, 1991.[ISI][Medline]
  51. Wagner JG and Roth RA. Neutrophil migration mechanisms, with an emphasis on the pulmonary vasculature. Pharmacol Rev 52: 349–374, 2000.[Abstract/Free Full Text]
  52. Williamson JR and Grisham JW. Electron microscopy of leukocytic margination and emigration in acute inflammation in dog pancreas. Am J Pathol 39: 239–256, 1961.[ISI][Medline]
  53. Yano M, Omoto Y, Yamakawa Y, Nakashima Y, Kiriyama M, Saito Y, and Fujii Y. Increased matrix metalloproteinase 9 activity and mRNA expression in lung ischemia-reperfusion injury. J Heart Lung Transplant 20: 679–686, 2001.[CrossRef][ISI][Medline]
  54. Zilberberg MD and Epstein SK. Acute lung injury in the medical ICU: comorbid conditions, age, etiology, and hospital outcome. Am J Respir Crit Care Med 157: 1159–1164, 1998.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 Exp. Biol. Med.Home page
F. Pirrone, S. M. Mazzola, C. Pastore, S. Paltrinieri, G. Sironi, P. Riccaboni, M. Viola, A. Passi, M. G. Clement, and M. Albertini
Activated Protein C Protection from Lung Inflammation in Endotoxin-Induced Injury
Experimental Biology and Medicine, November 1, 2008; 233(11): 1462 - 1468.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
P. R. Pedreira, E. Garcia-Prieto, D. Parra, A. Astudillo, E. Diaz, F. Taboada, and G. M. Albaiceta
Effects of melatonin in an experimental model of ventilator-induced lung injury
Am J Physiol Lung Cell Mol Physiol, November 1, 2008; 295(5): L820 - L827.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
G. M. Albaiceta, A. Gutierrez-Fernandez, D. Parra, A. Astudillo, E. Garcia-Prieto, F. Taboada, and A. Fueyo
Lack of matrix metalloproteinase-9 worsens ventilator-induced lung injury
Am J Physiol Lung Cell Mol Physiol, March 1, 2008; 294(3): L535 - L543.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
W.-F. Fang, J. H. Cho, Q. He, M.-C. Lin, C.-C. Wu, N. F. Voelkel, and I. S. Douglas
Lipid A fraction of LPS induces a discrete MAPK activation in acute lung injury
Am J Physiol Lung Cell Mol Physiol, August 1, 2007; 293(2): L336 - L344.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/4/L580    most recent
00270.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, J. H.
Right arrow Articles by Kang, K. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, J. H.
Right arrow Articles by Kang, K. H.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.